International task force issues first imaging guidance for PMR diagnosis

An international, multidisciplinary task force developed consensus recommendations on the role of ultrasound, MRI, and FDG-PET in polymyalgia rheumatica (PMR). The group states PMR remains primarily a clinical diagnosis, with imaging neither required to confirm nor exclude PMR at high or low clinical probability, but potentially useful in patients with intermediate pretest probability or atypical presentations. The recommendations also note no single imaging modality is sufficiently accurate as a first-line test, vascular imaging is noted when giant cell arteritis overlap is suspected, and imaging is not currently recommended for disease monitoring or outcome prediction.

Most relevant for: Clinicians evaluating patients with suspected or atypical polymyalgia rheumatica, including cases with possible overlap with giant cell arteritis.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.